Human placenta and fetal membranes express follistatin-related gene mRNA and protein

Journal of Endocrinological Investigation

Volumn 26, Issue 7, 2003, Pages 641-645

  Ciarmela, P ^a   Florio, P ^a   Toti, P ^a   Franchini, A ^b   Maguer Satta, V ^c   Ginanneschi, C ^a   Ottavian, E ^b   Petraglia, F ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

Activin; Amnion; Chorion; Decidua; Endothelium; Pregnancy; Trophoblast

Indexed keywords

ACTIVIN A; FOLLISTATIN; MEMBRANE PROTEIN; MESSENGER RNA;

AMNION CELL; AMNIOTIC FLUID CELL; ARTICLE; CESAREAN SECTION; DECIDUA; FEMALE; FETUS; FETUS MEMBRANE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GESTATION PERIOD; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; INDUCED ABORTION; PLACENTA; PREGNANCY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THIRD TRIMESTER PREGNANCY; TROPHOBLAST;

EID: 0142120531     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347022     Document Type: Article

References (30)

1. Petraglia F, Sawchenko P, Lim AT, Rivier J, Vale W. Localization, secretion, and action of inhibin in human placenta. Science 1987, 237: 187-9.
2. Petraglia F, Garuti GC, Calza L, et al. Inhibin subunits in human placenta: Localization and messenger ribonucleic acid levels during pregnancy. Am J Obstet Gynecol 1991, 165: 750-8.
3. Petraglia F, Calza L, Garuti GC, et al. Presence and synthesis of inhibin subunits in human decidua. J Clin Endocrinol Metab 1990, 71: 487-92.
4. Petraglia F, Anceschi MM, Calza L, et al. Inhibin and activin in human fetal membranes: Evidence for a local effect on prostaglandin release. J Clin Endocrinol Metab 1993, 77: 542-8.
5. Petraglia F, Florio P, Nappi C, Genzzani AR. Peptide signaling in human placenta and membranes: Autocrine, paracrine, and endocrine mechanisms. Endocr Rev 1996, 17: 156-86.
6. Florio P, Cobellis L, Luisi S, et al. Changes in inhibins and activin secretion in healthy and pathological pregnancies. Mol Cell Endocrinol 2001, 180: 123-30.
7. Petraglia F, Di Blasio AM, Florio P, et al. High levels of fetal membrane activin β A and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor. J Endocrinol 1997, 154: 95-101.
8. Schneider-Kolsky ME, Manuelpillai U, Waldron K, Dole A, Wallace EM. The distribution of activin and activin receptors in gestational tissues across human pregnancy and during labour. Placenta 2002, 23: 294-302
9. Jones RL, Salamonsen LA, Zhao YC, Either JF, Drummond AE, Findlay JK. Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; Consistent with a role for activins during decidualization. Mol Hum Reprod 2002, 8: 363-74
10. Petraglia F, Gallinelli A, Grande A, et al. Local production and action of follistatin in human placenta. J Clin Endocrinol Metab 1994, 78: 205-10.
11. Vaughan JM, Vale WW. Alpha 2-macroglobulin is a binding protein of inhibin and activin. Endocrinology 1993, 132: 2038-50.
12. McFarlane JR, Foulds LM, O'Connor AE, et al. Uterine milk protein, a novel activin-binding protein, is present in ovine allantoic fluid. Endocrinology 1999, 140: 4745-52
13. Petraglia F, Vaughan J, Vale W. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells. Proc Natl Acad Sci USA 1989, 86: 5114-7.
14. Florio P, Lombardo M, Gallo R, et al. Activin A, corticotropin-releasing factor and prostaglandin F2 α increase immunoreactive oxytocin release from cultured human placental cells. Placenta 1996, 17: 307-11.
15. Caniggia I, Lye SJ, Cross JC. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology 1997, 138: 3976-86.
16. Ueno M, Nishimatsu S, Murakami K. Activin as a cell differentiation factor. Prog Growth Factor Res 1990, 2: 113-24.
17. Hayette S, Gadoux M, Martel S, et al. FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 1998, 16: 2949-54
18. Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H. Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J Biol Chem 2000, 275: 40788-96.
19. Tsuchida K, Matsuzaki T, Yamakawa N, Liu Z, Sugino H. Intracellular and extracellular control of activin function by novel regulatory molecules. Mol Cell Endocrinol 2001, 180: 25-31
20. Maguer-Satta V, Bartholin L, Jeanpierre S, et al. Expression of FLRG, a novel activin A ligand, is regulated by TGF-β and during hematopoiesis. Exp Hematol 2001, 29: 301-8.
21. Bartholin L, Maguer-Satta V, Hayette S, et al. FLRG, an activin-binding protein, is a new target of TGF-β transcription activation through Smad proteins. Oncogene 2001, 20: 5409-19.
22. Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL. Human follistatin-related protein: A structural homologue of follistatin with nuclear localization. Endocrinology 2001, 142: 3426-34.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162: 156-9.
24. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997, 25: 3389-402
25. 2-glycoprotein in human placenta. Arkh Anat Gistol Embriol 1990, 99: 74-6.
26. McCarthy SA, Bicknell R. Inhibition of vascular endothelial cell growth by activin bA. J Biol Chem 1993, 5: 268.
27. Schneider-Kolsky M, Manuelpillai U, Gargett C, Wallace EM. Activin betaA-subunit and activin receptors in human myometrium at term and during labour. BJOG 2001, 108: 869-74
28. Kozian DH, Ziche M, Augustin HG. The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Lab Invest 1997, 76: 267-76.
29. Breit S, Ashman K, Wilting J, et al. The N-myc oncogene in human neuroblastoma cells: Down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res 2000, 60: 4596-601.
30. Hino M, Nishizawa Y, Tatsumi N, Tojo A, Morii H. Down-modulation of c-kit mRNA and protein expression by erythroid differentiation factor/activin A. FEBS Lett 1995, 374: 69-71.